These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 24222525)

  • 41. Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone.
    Varinska L; van Wijhe M; Belleri M; Mitola S; Perjesi P; Presta M; Koolwijk P; Ivanova L; Mojzis J
    Eur J Pharmacol; 2012 Sep; 691(1-3):125-33. PubMed ID: 22721615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A zebrafish in vivo phenotypic assay to identify 3-aminothiophene-2-carboxylic acid-based angiogenesis inhibitors.
    Papakyriakou A; Kefalos P; Sarantis P; Tsiamantas C; Xanthopoulos KP; Vourloumis D; Beis D
    Assay Drug Dev Technol; 2014; 12(9-10):527-35. PubMed ID: 25506802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
    Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
    Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and structure-activity relationships of constrained heterocyclic analogues of combretastatin A4.
    Arthuis M; Pontikis R; Chabot GG; Seguin J; Quentin L; Bourg S; Morin-Allory L; Florent JC
    ChemMedChem; 2011 Sep; 6(9):1693-705. PubMed ID: 21732536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro.
    Fernand VE; Losso JN; Truax RE; Villar EE; Bwambok DK; Fakayode SO; Lowry M; Warner IM
    Chem Biol Interact; 2011 Jul; 192(3):220-32. PubMed ID: 21457705
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-angiogenic function of tocotrienol.
    Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new chiral 2-(ethylthio)-thiazolone analogue shows strong antitumor activities by inducing cancer cell apoptosis and inhibiting angiogenesis.
    Song H; Kai M; Liu X; Yin W; Zeng Q; Yao X; Wang R
    Anticancer Drugs; 2012 Oct; 23(9):914-22. PubMed ID: 22614105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An Ex Vivo Tissue Culture Model for Anti-angiogenic Drug Testing.
    Azimi MS; Lacey M; Mondal D; Murfee WL
    Methods Mol Biol; 2016; 1464():85-95. PubMed ID: 27858358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Imaged-based high-throughput screening for anti-angiogenic drug discovery.
    Evensen L; Link W; Lorens JB
    Curr Pharm Des; 2010; 16(35):3958-63. PubMed ID: 21158729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advancing toxicology research using in vivo high throughput toxicology with small fish models.
    Planchart A; Mattingly CJ; Allen D; Ceger P; Casey W; Hinton D; Kanungo J; Kullman SW; Tal T; Bondesson M; Burgess SM; Sullivan C; Kim C; Behl M; Padilla S; Reif DM; Tanguay RL; Hamm J
    ALTEX; 2016; 33(4):435-452. PubMed ID: 27328013
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Organotypic brain slice cultures as a model to study angiogenesis of brain vessels.
    Hutter-Schmid B; Kniewallner KM; Humpel C
    Front Cell Dev Biol; 2015; 3():52. PubMed ID: 26389117
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cellular context-mediated Akt dynamics regulates MAP kinase signaling thresholds during angiogenesis.
    Hellesøy M; Lorens JB
    Mol Biol Cell; 2015 Jul; 26(14):2698-711. PubMed ID: 26023089
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular deconstruction, detection, and computational prediction of microenvironment-modulated cellular responses to cancer therapeutics.
    Labarge MA; Parvin B; Lorens JB
    Adv Drug Deliv Rev; 2014 Apr; 69-70():123-31. PubMed ID: 24582543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contextual compound screening for improved therapeutic discovery.
    Evensen L; Odlo K; Micklem DR; Littlewood-Evans A; Wood J; Kuzniewski C; Altmann KH; Hansen TV; Lorens JB
    Chembiochem; 2013 Dec; 14(18):2512-8. PubMed ID: 24222525
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacologic characterization of a kinetic in vitro human co-culture angiogenesis model using clinically relevant compounds.
    Wolfe A; O'Clair B; Groppi VE; McEwen DP
    J Biomol Screen; 2013 Dec; 18(10):1234-45. PubMed ID: 24019254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Image-based high-throughput screening for inhibitors of angiogenesis.
    Evensen L; Link W; Lorens JB
    Methods Mol Biol; 2013; 931():139-51. PubMed ID: 23027002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
    Evensen L; Micklem DR; Link W; Lorens JB
    Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fishing anti(lymph)angiogenic drugs with zebrafish.
    García-Caballero M; Quesada AR; Medina MA; Marí-Beffa M
    Drug Discov Today; 2018 Feb; 23(2):366-374. PubMed ID: 29081356
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.